Report Detail

Pharma & Healthcare Impact of COVID-19 Outbreak on EPA / DHA/ALA (Omega 3), Global Market Research Report 2020

  • RnM3973587
  • |
  • 21 May, 2020
  • |
  • Global
  • |
  • 98 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 EPA / DHA/ALA (Omega 3) Market Overview

  • 1.1 Product Overview and Scope of EPA / DHA/ALA (Omega 3)
  • 1.2 Covid-19 Impact on EPA / DHA/ALA (Omega 3) Segment by Type
    • 1.2.1 Global EPA / DHA/ALA (Omega 3) Sales Growth Rate Comparison by Type (2021-2026)
    • 1.2.2 Fish Oil
    • 1.2.3 Algae Oil
  • 1.3 Covid-19 Impact on EPA / DHA/ALA (Omega 3) Segment by Application
    • 1.3.1 EPA / DHA/ALA (Omega 3) Sales Comparison by Application: 2020 VS 2026
    • 1.3.2 Dietary Supplements
    • 1.3.3 Functional Foods & Beverages
    • 1.3.4 Others
  • 1.4 Covid-19 Impact on Global EPA / DHA/ALA (Omega 3) Market Size Estimates and Forecasts
    • 1.4.1 Global EPA / DHA/ALA (Omega 3) Revenue 2015-2026
    • 1.4.2 Global EPA / DHA/ALA (Omega 3) Sales 2015-2026
    • 1.4.3 EPA / DHA/ALA (Omega 3) Market Size by Region: 2020 Versus 2026
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on EPA / DHA/ALA (Omega 3) Industry
  • 1.7 COVID-19 Impact: EPA / DHA/ALA (Omega 3) Market Trends

2 Covid-19 Impact on Global EPA / DHA/ALA (Omega 3) Market Competition by Manufacturers

  • 2.1 Global EPA / DHA/ALA (Omega 3) Sales Market Share by Manufacturers (2015-2020)
  • 2.2 Global EPA / DHA/ALA (Omega 3) Revenue Share by Manufacturers (2015-2020)
  • 2.3 Global EPA / DHA/ALA (Omega 3) Average Price by Manufacturers (2015-2020)
  • 2.4 Manufacturers EPA / DHA/ALA (Omega 3) Manufacturing Sites, Area Served, Product Type
  • 2.5 EPA / DHA/ALA (Omega 3) Market Competitive Situation and Trends
    • 2.5.1 EPA / DHA/ALA (Omega 3) Market Concentration Rate
    • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
    • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 2.7 Primary Interviews with Key EPA / DHA/ALA (Omega 3) Players (Opinion Leaders)

3 Covid-19 Impact on EPA / DHA/ALA (Omega 3) Retrospective Market Scenario by Region

  • 3.1 Global EPA / DHA/ALA (Omega 3) Retrospective Market Scenario in Sales by Region: 2015-2020
  • 3.2 Global EPA / DHA/ALA (Omega 3) Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 3.3 North America EPA / DHA/ALA (Omega 3) Market Facts & Figures by Country
    • 3.3.1 North America EPA / DHA/ALA (Omega 3) Sales by Country
    • 3.3.2 North America EPA / DHA/ALA (Omega 3) Sales by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe EPA / DHA/ALA (Omega 3) Market Facts & Figures by Country
    • 3.4.1 Europe EPA / DHA/ALA (Omega 3) Sales by Country
    • 3.4.2 Europe EPA / DHA/ALA (Omega 3) Sales by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific EPA / DHA/ALA (Omega 3) Market Facts & Figures by Region
    • 3.5.1 Asia Pacific EPA / DHA/ALA (Omega 3) Sales by Region
    • 3.5.2 Asia Pacific EPA / DHA/ALA (Omega 3) Sales by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
  • 3.6 Latin America EPA / DHA/ALA (Omega 3) Market Facts & Figures by Country
    • 3.6.1 Latin America EPA / DHA/ALA (Omega 3) Sales by Country
    • 3.6.2 Latin America EPA / DHA/ALA (Omega 3) Sales by Country
    • 3.6.3 Mexico
    • 3.6.3 Brazil
    • 3.6.3 Argentina
  • 3.7 Middle East and Africa EPA / DHA/ALA (Omega 3) Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa EPA / DHA/ALA (Omega 3) Sales by Country
    • 3.7.2 Middle East and Africa EPA / DHA/ALA (Omega 3) Sales by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Covid-19 Impact on Global EPA / DHA/ALA (Omega 3) Historic Market Analysis by Type

  • 4.1 Global EPA / DHA/ALA (Omega 3) Sales Market Share by Type (2015-2020)
  • 4.2 Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Type (2015-2020)
  • 4.3 Global EPA / DHA/ALA (Omega 3) Price Market Share by Type (2015-2020)
  • 4.4 Global EPA / DHA/ALA (Omega 3) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Covid-19 Impact on Global EPA / DHA/ALA (Omega 3) Historic Market Analysis by Application

  • 5.1 Global EPA / DHA/ALA (Omega 3) Sales Market Share by Application (2015-2020)
  • 5.2 Global EPA / DHA/ALA (Omega 3) Revenue Market Share by Application (2015-2020)
  • 5.3 Global EPA / DHA/ALA (Omega 3) Price by Application (2015-2020)

6 Company Profiles and Key Figures in EPA / DHA/ALA (Omega 3) Business

  • 6.1 EPAX
    • 6.1.1 Corporation Information
    • 6.1.2 EPAX Description, Business Overview and Total Revenue
    • 6.1.3 EPAX EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2015-2020)
    • 6.1.4 EPAX Products Offered
    • 6.1.5 EPAX Recent Development and Response to COVID-19
  • 6.2 Golden Omega
    • 6.2.1 Golden Omega Corporation Information
    • 6.2.2 Golden Omega Description, Business Overview and Total Revenue
    • 6.2.3 Golden Omega EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2015-2020)
    • 6.2.4 Golden Omega Products Offered
    • 6.2.5 Golden Omega Recent Development and Response to COVID-19
  • 6.3 TASA
    • 6.3.1 TASA Corporation Information
    • 6.3.2 TASA Description, Business Overview and Total Revenue
    • 6.3.3 TASA EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2015-2020)
    • 6.3.4 TASA Products Offered
    • 6.3.5 TASA Recent Development and Response to COVID-19
  • 6.4 Omega Protein
    • 6.4.1 Omega Protein Corporation Information
    • 6.4.2 Omega Protein Description, Business Overview and Total Revenue
    • 6.4.3 Omega Protein EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 Omega Protein Products Offered
    • 6.4.5 Omega Protein Recent Development and Response to COVID-19
  • 6.5 Croda
    • 6.5.1 Croda Corporation Information
    • 6.5.2 Croda Description, Business Overview and Total Revenue
    • 6.5.3 Croda EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2015-2020)
    • 6.5.4 Croda Products Offered
    • 6.5.5 Croda Recent Development and Response to COVID-19
  • 6.6 KD Pharma
    • 6.6.1 KD Pharma Corporation Information
    • 6.6.2 KD Pharma Description, Business Overview and Total Revenue
    • 6.6.3 KD Pharma EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2015-2020)
    • 6.6.4 KD Pharma Products Offered
    • 6.6.5 KD Pharma Recent Development and Response to COVID-19
  • 6.7 GC Rieber
    • 6.6.1 GC Rieber Corporation Information
    • 6.6.2 GC Rieber Description, Business Overview and Total Revenue
    • 6.6.3 GC Rieber EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 GC Rieber Products Offered
    • 6.7.5 GC Rieber Recent Development and Response to COVID-19
  • 6.8 Polaris
    • 6.8.1 Polaris Corporation Information
    • 6.8.2 Polaris Description, Business Overview and Total Revenue
    • 6.8.3 Polaris EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2015-2020)
    • 6.8.4 Polaris Products Offered
    • 6.8.5 Polaris Recent Development and Response to COVID-19
  • 6.9 Auqi
    • 6.9.1 Auqi Corporation Information
    • 6.9.2 Auqi Description, Business Overview and Total Revenue
    • 6.9.3 Auqi EPA / DHA/ALA (Omega 3) Sales, Revenue and Gross Margin (2015-2020)
    • 6.9.4 Auqi Products Offered
    • 6.9.5 Auqi Recent Development and Response to COVID-19

7 EPA / DHA/ALA (Omega 3) Manufacturing Cost Analysis

  • 7.1 EPA / DHA/ALA (Omega 3) Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Raw Materials Price Trend
    • 7.1.3 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of EPA / DHA/ALA (Omega 3)
  • 7.4 EPA / DHA/ALA (Omega 3) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 EPA / DHA/ALA (Omega 3) Distributors List
  • 8.3 EPA / DHA/ALA (Omega 3) Customers

9 Market Dynamics

  • 9.1 Market Trends
  • 9.2 Opportunities and Drivers
  • 9.3 Challenges
  • 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

  • 10.1 Global EPA / DHA/ALA (Omega 3) Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of EPA / DHA/ALA (Omega 3) by Type (2021-2026)
    • 10.1.2 Global Forecasted Revenue of EPA / DHA/ALA (Omega 3) by Type (2021-2026)
  • 10.2 EPA / DHA/ALA (Omega 3) Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of EPA / DHA/ALA (Omega 3) by Application (2021-2026)
    • 10.2.2 Global Forecasted Revenue of EPA / DHA/ALA (Omega 3) by Application (2021-2026)
  • 10.3 EPA / DHA/ALA (Omega 3) Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of EPA / DHA/ALA (Omega 3) by Region (2021-2026)
    • 10.3.2 Global Forecasted Revenue of EPA / DHA/ALA (Omega 3) by Region (2021-2026)
  • 10.4 North America EPA / DHA/ALA (Omega 3) Estimates and Projections (2021-2026)
  • 10.5 Europe EPA / DHA/ALA (Omega 3) Estimates and Projections (2021-2026)
  • 10.6 Asia Pacific EPA / DHA/ALA (Omega 3) Estimates and Projections (2021-2026)
  • 10.7 Latin America EPA / DHA/ALA (Omega 3) Estimates and Projections (2021-2026)
  • 10.8 Middle East and Africa EPA / DHA/ALA (Omega 3) Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
    Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the EPA / DHA/ALA (Omega 3) market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
    This report also analyzes the impact of Coronavirus COVID-19 on the EPA / DHA/ALA (Omega 3) industry.

    Segment by Type, the EPA / DHA/ALA (Omega 3) market is segmented into
    Fish Oil
    Algae Oil

    Segment by Application
    Dietary Supplements
    Functional Foods & Beverages
    Others

    Global EPA / DHA/ALA (Omega 3) Market: Regional Analysis
    The EPA / DHA/ALA (Omega 3) market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
    The key regions covered in the EPA / DHA/ALA (Omega 3) market report are:
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    Global EPA / DHA/ALA (Omega 3) Market: Competitive Analysis
    This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

    The major players in global EPA / DHA/ALA (Omega 3) market include:
    EPAX
    Golden Omega
    TASA
    Omega Protein
    Croda
    KD Pharma
    GC Rieber
    Polaris
    Auqi


    Summary:
    Get latest Market Research Reports on EPA / DHA/ALA (Omega 3). Industry analysis & Market Report on EPA / DHA/ALA (Omega 3) is a syndicated market report, published as Impact of COVID-19 Outbreak on EPA / DHA/ALA (Omega 3), Global Market Research Report 2020. It is complete Research Study and Industry Analysis of EPA / DHA/ALA (Omega 3) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,350.23
    3,525.34
    4,700.46
    2,608.05
    3,912.08
    5,216.11
    311,373.00
    467,059.50
    622,746.00
    219,046.86
    328,570.29
    438,093.72
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report